These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3124003)

  • 1. Folic acid metabolism and its disruption by pharmacologic agents.
    Huennekens FM; Duffy TH; Vitols KS
    NCI Monogr; 1987; (5):1-8. PubMed ID: 3124003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
    Chello PL; McQueen CA; DeAngelis LM; Bertino JR
    Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.
    Pizzorno G; Moroson BA; Cashmore AR; Russello O; Mayer JR; Galivan J; Bunni MA; Priest DG; Beardsley GP
    Cancer Res; 1995 Feb; 55(3):566-73. PubMed ID: 7834626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of folate antagonists versus enzymatic folate depletion on folate and thymidine enzymes in cultured mammalian cells.
    Chello PL; McQueen CA; DeAngelis LM; Bertino JR
    Cancer Treat Rep; 1977 Jul; 61(4):539-48. PubMed ID: 195727
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mathematical description and study of the folic acid cycle reactions].
    Vorontsov IN; Greshilov MM; Belousova AK; Gerasimova GK
    Biokhimiia; 1980 Jan; 45(1):83-97. PubMed ID: 6783126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of human dihydrofolate reductase activity and expression.
    Abali EE; Skacel NE; Celikkaya H; Hsieh YC
    Vitam Horm; 2008; 79():267-92. PubMed ID: 18804698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structures of dihydrofolate reductase-thymidylate synthase of Trypanosoma cruzi in the folate-free state and in complex with two antifolate drugs, trimetrexate and methotrexate.
    Senkovich O; Schormann N; Chattopadhyay D
    Acta Crystallogr D Biol Crystallogr; 2009 Jul; 65(Pt 7):704-16. PubMed ID: 19564691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS; Galivan J; Wright JE; Rosowsky A
    Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory control of tetrahydrofolate coenzymes in folate auxotrophs.
    Albrecht AM
    Cancer Treat Rep; 1977 Jul; 61(4):533-8. PubMed ID: 301776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of biochemical criteria for sensitivity of tumor cells to methotrexate by means of mathematic simulation].
    Belousova AK; Gerasimova GK; Vorontsov IN; Greshilov MM
    Biokhimiia; 1980 Apr; 45(4):609-21. PubMed ID: 6769505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of antifolate resistance.
    Assaraf YG
    Cancer Metastasis Rev; 2007 Mar; 26(1):153-81. PubMed ID: 17333344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and rationale for novel antifolates.
    Bertino JR; Sobrero A; Mini E; Moroson BA; Cashmore A
    NCI Monogr; 1987; (5):87-91. PubMed ID: 3431593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LY231514, a pyrrolo[2,3-d]pyrimidine-based antifolate that inhibits multiple folate-requiring enzymes.
    Shih C; Chen VJ; Gossett LS; Gates SB; MacKellar WC; Habeck LL; Shackelford KA; Mendelsohn LG; Soose DJ; Patel VF; Andis SL; Bewley JR; Rayl EA; Moroson BA; Beardsley GP; Kohler W; Ratnam M; Schultz RM
    Cancer Res; 1997 Mar; 57(6):1116-23. PubMed ID: 9067281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate metabolic pathways in Leishmania.
    Vickers TJ; Beverley SM
    Essays Biochem; 2011; 51():63-80. PubMed ID: 22023442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of methotrexate polyglutamylation and cellular energy metabolism in inhibition of methotrexate binding to dihydrofolate reductase by 5-formyltetrahydrofolate in Ehrlich ascites tumor cells in vitro.
    Matherly LH; Fry DW; Goldman ID
    Cancer Res; 1983 Jun; 43(6):2694-9. PubMed ID: 6189586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer modelling of antifolate inhibition of folate metabolism using hybrid functional petri nets.
    Assaraf YG; Ifergan I; Kadry WN; Pinter RY
    J Theor Biol; 2006 Jun; 240(4):637-47. PubMed ID: 16352313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of thymidylate synthetase and dihydrofolate reductase enzymes in vitro and in vivo.
    Kawai M; Hillcoat BL
    Cancer Res; 1974 Jul; 34(7):1619-26. PubMed ID: 4833915
    [No Abstract]   [Full Text] [Related]  

  • 19. Folate and antifolate pharmacology.
    Kamen B
    Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-30-S18-39. PubMed ID: 9420019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential methotrexate and 5-fluorouracil: mechanisms of synergy.
    Bertino JR; Mini E; Fernandes DJ
    Semin Oncol; 1983 Jun; 10(2 Suppl 2):2-5. PubMed ID: 6867754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.